Literature DB >> 15866338

Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.

Igor V Zhigaltsev1, Norbert Maurer, Quet-Fah Akhong, Robert Leone, Esther Leng, Jinfang Wang, Sean C Semple, Pieter R Cullis.   

Abstract

A comparative study of the loading and retention properties of three structurally very closely related vinca alkaloids (vincristine, vinorelbine and vinblastine) in liposomal formulations has been performed. All three vinca alkaloids showed high levels of encapsulation when accumulated into egg sphingomyelin/cholesterol vesicles in response to a transmembrane pH gradient generated by the use of the ionophore A23187 and encapsulated MgSO4. However, despite the close similarities of their structures the different vinca drugs exhibited very different release behavior, with vinblastine and vinorelbine being released faster than vincristine both in vitro and in vivo. The differences in loading and retention can be related to the lipophilicity of the drugs tested, where the more hydrophobic drugs are released more rapidly. It was also found that increasing the drug-to-lipid ratio significantly enhanced the retention of vinca alkaloids when the ionophore-based method was used for drug loading. In contrast, drug retention was not dependent on the initial drug-to-lipid ratio for vinca drugs loaded into liposomes containing an acidic citrate buffer. The differences in retention can be explained on the basis of differences in the physical state of the drug inside the liposomes. The drug-to-lipid ratio dependence of retention observed for liposomes loaded with the ionophore technique may provide a way to improve the retention characteristics of liposomal formulations of vinca drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866338     DOI: 10.1016/j.jconrel.2005.01.010

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  35 in total

1.  Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors.

Authors:  Zhao Yan; Zhong-ling Zhu; Zheng-zi Qian; Ge Hu; Hua-qing Wang; Wan-hui Liu; Guang Cheng
Journal:  Acta Pharmacol Sin       Date:  2012-06       Impact factor: 6.150

Review 2.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 3.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

4.  Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization.

Authors:  Amit K Jain; Kaushik Thanki; Sanyog Jain
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

5.  Multiple lipid compartments slow vesicle contents release in lipases and serum.

Authors:  Cecile Boyer; Joseph A Zasadzinski
Journal:  ACS Nano       Date:  2007-10       Impact factor: 15.881

Review 6.  Scientific and Regulatory Considerations for Generic Complex Drug Products Containing Nanomaterials.

Authors:  Nan Zheng; Dajun D Sun; Peng Zou; Wenlei Jiang
Journal:  AAPS J       Date:  2017-01-23       Impact factor: 4.009

7.  Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer.

Authors:  Nilesh A Patankar; Dawn Waterhouse; Dita Strutt; Malathi Anantha; Marcel B Bally
Journal:  Invest New Drugs       Date:  2012-05-22       Impact factor: 3.850

Review 8.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

9.  Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine.

Authors:  Charles O Noble; Zexiong Guo; Mark E Hayes; James D Marks; John W Park; Christopher C Benz; Dmitri B Kirpotin; Daryl C Drummond
Journal:  Cancer Chemother Pharmacol       Date:  2009-01-30       Impact factor: 3.333

10.  Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM).

Authors:  Yuangang Zu; Yu Zhang; Xiuhua Zhao; Qi Zhang; Yang Liu; Ru Jiang
Journal:  Int J Nanomedicine       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.